<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://podcasthealth.com/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl?v=2"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	 xmlns:ssp="https://castos.com/seriously-simple-podcasting/namespace/1.0"
	>
		<channel>
		<title>Translating Aging</title>
		<atom:link href="https://podcasthealth.com/feed/podcast/translating-aging/" rel="self" type="application/rss+xml"/>
		<link>https://podcasthealth.com/show/translating-aging/</link>
		<description>On Translating Aging, we talk with the worldwide community of researchers, entrepreneurs, and investors who are moving longevity science from the lab to the clinic. We bring you a commanding view of the entire field, in the words of the people and companies who are moving it forward today. The podcast is sponsored by BioAge labs, a clinical-stage biotechnology company developing therapies to extend human healthspan by targeting the molecular causes of aging.</description>
		<lastBuildDate>Thu, 15 Oct 2026 12:27:10 +0000</lastBuildDate>
		<language>en-US</language>
		<copyright>&#xA9; 2026 PodcastHealth</copyright>
		<itunes:subtitle>Health + Hospital Podcasts</itunes:subtitle>
		<itunes:author>PodcastHealth</itunes:author>
		<itunes:summary>On Translating Aging, we talk with the worldwide community of researchers, entrepreneurs, and investors who are moving longevity science from the lab to the clinic. We bring you a commanding view of the entire field, in the words of the people and companies who are moving it forward today. The podcast is sponsored by BioAge labs, a clinical-stage biotechnology company developing therapies to extend human healthspan by targeting the molecular causes of aging.</itunes:summary>
		<itunes:owner>
			<itunes:name>PodcastHealth</itunes:name>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/trans.jpg"></itunes:image>
			<image>
				<url>https://podcasthealth.com/wp-content/uploads/2025/07/trans.jpg</url>
				<title>Translating Aging</title>
				<link>https://podcasthealth.com/show/translating-aging/</link>
			</image>
		<podcast:locked>yes</podcast:locked>
		<podcast:guid>37b25ae3-77ff-5a3f-b72f-0e76ab57b833</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.17.0" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=7.1.3</generator>

<item>
	<title>A Promise Kept — Phase 1 Data for a 7-KC-Clearing Drug (Oki O&#8217;Connor, Cyclarity Tx)</title>
	<link>https://podcasthealth.com/podcast/a-promise-kept-phase-1-data-for-a-7-kc-clearing-drug-oki-oconnor-cyclarity-tx/</link>
	<pubDate>Wed, 17 Jun 2026 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/a-promise-kept-phase-1-data-for-a-7-kc-clearing-drug-oki-oconnor-cyclarity-tx/</guid>
	<description><![CDATA[Matthew &#8220;Oki&#8221; O&#8217;Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new class of medicines designed not to slow the accumulation of vascular damage but to reverse it. Oki and Chris first crossed paths as postdocs at Lawrence Berkeley National Lab in the mid-2000s — Oki was in Irina [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Matthew &#8220;Oki&#8221; O&#8217;Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new class of medicines designed not to slow the accumulation of vascular damage but to reverse it. Oki and Chris firs]]></itunes:subtitle>
	<content:encoded><![CDATA[Matthew &#8220;Oki&#8221; O&#8217;Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new class of medicines designed not to slow the accumulation of vascular damage but to reverse it. Oki and Chris first crossed paths as postdocs at Lawrence Berkeley National Lab in the mid-2000s — Oki was in Irina [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/182263/a-promise-kept-phase-1-data-for-a-7-kc-clearing-drug-oki-oconnor-cyclarity-tx.mp3" length="57912852" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Matthew &#8220;Oki&#8221; O&#8217;Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new class of medicines designed not to slow the accumulation of vascular damage but to reverse it. Oki and Chris first crossed paths as postdocs at Lawrence Berkeley National Lab in the mid-2000s — Oki was in Irina [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>A Promise Kept — Phase 1 Data for a 7-KC-Clearing Drug (Oki O&#8217;Connor, Cyclarity Tx)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>40:13</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Beyond senolytics: senoadaptive drugs &#038; clinical data on GPX4 modulation (Dr. Marco Quarta, Rubedo)</title>
	<link>https://podcasthealth.com/podcast/beyond-senolytics-senoadaptive-drugs-clinical-data-on-gpx4-modulation-dr-marco-quarta-rubedo/</link>
	<pubDate>Wed, 20 May 2026 08:56:50 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/beyond-senolytics-senoadaptive-drugs-clinical-data-on-gpx4-modulation-dr-marco-quarta-rubedo/</guid>
	<description><![CDATA[Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that target the pathological cell states that drive age-associated disease. Marco&#8217;s first appearance on the show was three years ago, in February 2023 (Episode 35), when Rubedo was a much earlier-stage company committed to the then-contrarian premise that [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that target the pathological cell states that drive age-associated disease. Marco&#8217;s first appearance on the show ]]></itunes:subtitle>
	<content:encoded><![CDATA[Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that target the pathological cell states that drive age-associated disease. Marco&#8217;s first appearance on the show was three years ago, in February 2023 (Episode 35), when Rubedo was a much earlier-stage company committed to the then-contrarian premise that [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/179186/beyond-senolytics-senoadaptive-drugs-clinical-data-on-gpx4-modulation-dr-marco-quarta-rubedo.mp3" length="67129835" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that target the pathological cell states that drive age-associated disease. Marco&#8217;s first appearance on the show was three years ago, in February 2023 (Episode 35), when Rubedo was a much earlier-stage company committed to the then-contrarian premise that [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Beyond senolytics: senoadaptive drugs &#038; clinical data on GPX4 modulation (Dr. Marco Quarta, Rubedo)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>46:37</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Investing in the Future of Longevity (Sergey Jakimov, Managing Partner, LongeVC)</title>
	<link>https://podcasthealth.com/podcast/investing-in-the-future-of-longevity-sergey-jakimov-managing-partner-longevc/</link>
	<pubDate>Wed, 13 Aug 2025 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/investing-in-the-future-of-longevity-sergey-jakimov-managing-partner-longevc/</guid>
	<description><![CDATA[Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe&#8217;s most active longevity-focused venture capital firms, currently raising its second fund targeting $250 million. In this episode, Chris and Sergey explore the investment landscape shaping longevity biotechnology today. They discuss LongeVC&#8217;s pragmatic approach to longevity investing—focusing on disease-modifying therapies rather than targeting [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe&#8217;s most active longevity-focused venture capital firms, currently raising its second fund targeting $250 million. In this episode, Chris and Sergey explore the investmen]]></itunes:subtitle>
	<content:encoded><![CDATA[Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe&#8217;s most active longevity-focused venture capital firms, currently raising its second fund targeting $250 million. In this episode, Chris and Sergey explore the investment landscape shaping longevity biotechnology today. They discuss LongeVC&#8217;s pragmatic approach to longevity investing—focusing on disease-modifying therapies rather than targeting [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/119034/investing-in-the-future-of-longevity-sergey-jakimov-managing-partner-longevc.mp3" length="123522252" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe&#8217;s most active longevity-focused venture capital firms, currently raising its second fund targeting $250 million. In this episode, Chris and Sergey explore the investment landscape shaping longevity biotechnology today. They discuss LongeVC&#8217;s pragmatic approach to longevity investing—focusing on disease-modifying therapies rather than targeting [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Investing in the Future of Longevity (Sergey Jakimov, Managing Partner, LongeVC)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>51:28</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Molecules to medicine: The translational landscape of aging interventions (Panel discussion at BAAM 2025)</title>
	<link>https://podcasthealth.com/podcast/molecules-to-medicine-the-translational-landscape-of-aging-interventions-panel-discussion-at-baam-2025/</link>
	<pubDate>Wed, 09 Jul 2025 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/molecules-to-medicine-the-translational-landscape-of-aging-interventions-panel-discussion-at-baam-2025/</guid>
	<description><![CDATA[In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay Area Aging Meeting at UCSF, bringing together six leading voices across the aging research ecosystem to tackle one of the field&#8217;s most critical challenges: how to move promising discoveries from the laboratory to therapies that can benefit [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay Area Aging Meeting at UCSF, bringing together six leading voices across the aging research ecosystem to tackle one of the field&#8217;s most cr]]></itunes:subtitle>
	<content:encoded><![CDATA[In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay Area Aging Meeting at UCSF, bringing together six leading voices across the aging research ecosystem to tackle one of the field&#8217;s most critical challenges: how to move promising discoveries from the laboratory to therapies that can benefit [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/94584/molecules-to-medicine-the-translational-landscape-of-aging-interventions-panel-discussion-at-baam-2025.mp3" length="115144130" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay Area Aging Meeting at UCSF, bringing together six leading voices across the aging research ecosystem to tackle one of the field&#8217;s most critical challenges: how to move promising discoveries from the laboratory to therapies that can benefit [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Molecules to medicine: The translational landscape of aging interventions (Panel discussion at BAAM 2025)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>47:59</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Partial epigenetic reprogramming: the &#8220;holy grail&#8221; for aging therapeutics (Michael Ringel, Life Biosciences)</title>
	<link>https://podcasthealth.com/podcast/partial-epigenetic-reprogramming-the-holy-grail-for-aging-therapeutics-michael-ringel-life-biosciences/</link>
	<pubDate>Wed, 04 Jun 2025 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/partial-epigenetic-reprogramming-the-holy-grail-for-aging-therapeutics-michael-ringel-life-biosciences/</guid>
	<description><![CDATA[Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. Michael became COO of Life just a few months ago, but he&#8217;s been advising the company since 2018. Prior to this year, he was managing director and senior partner at [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. Michael became COO of Life just a few months ago, but he&#8217;s been]]></itunes:subtitle>
	<content:encoded><![CDATA[Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. Michael became COO of Life just a few months ago, but he&#8217;s been advising the company since 2018. Prior to this year, he was managing director and senior partner at [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/94586/partial-epigenetic-reprogramming-the-holy-grail-for-aging-therapeutics-michael-ringel-life-biosciences.mp3" length="54651781" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. Michael became COO of Life just a few months ago, but he&#8217;s been advising the company since 2018. Prior to this year, he was managing director and senior partner at [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Partial epigenetic reprogramming: the &#8220;holy grail&#8221; for aging therapeutics (Michael Ringel, Life Biosciences)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>37:57</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Cell Reset Therapeutics to Extend Healthspan and Lifespan (Janine Sengstack, Junevity)</title>
	<link>https://podcasthealth.com/podcast/cell-reset-therapeutics-to-extend-healthspan-and-lifespan-janine-sengstack-junevity/</link>
	<pubDate>Wed, 02 Apr 2025 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/cell-reset-therapeutics-to-extend-healthspan-and-lifespan-janine-sengstack-junevity/</guid>
	<description><![CDATA[Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what they term &#8220;Cell Reset therapeutics.&#8221; The company recently secured $10 million in seed funding. In this episode, Chris and Janine explore the innovative platform Janine developed during [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what they term &#8220;Cell Reset therapeutics.&#8221; The company recently secured $]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what they term &#8220;Cell Reset therapeutics.&#8221; The company recently secured $10 million in seed funding. In this episode, Chris and Janine explore the innovative platform Janine developed during [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/94588/cell-reset-therapeutics-to-extend-healthspan-and-lifespan-janine-sengstack-junevity.mp3" length="26434600" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what they term &#8220;Cell Reset therapeutics.&#8221; The company recently secured $10 million in seed funding. In this episode, Chris and Janine explore the innovative platform Janine developed during [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Cell Reset Therapeutics to Extend Healthspan and Lifespan (Janine Sengstack, Junevity)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>36:43</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Building the Infrastructure for Longevity Medicine: ARPA-H&#8217;s PROSPR Program (Dr. Andrew Brack, Program Manager)</title>
	<link>https://podcasthealth.com/podcast/building-the-infrastructure-for-longevity-medicine-arpa-hs-prospr-program-dr-andrew-brack-program-manager/</link>
	<pubDate>Thu, 09 Jan 2025 13:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/building-the-infrastructure-for-longevity-medicine-arpa-hs-prospr-program-dr-andrew-brack-program-manager/</guid>
	<description><![CDATA[Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human healthspan. In this wide-ranging conversation, Chris and Andrew explore how PROSPR plans to accelerate the development of therapies that target aging itself by building the regulatory [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human healthspan. In this wide-ranging conversat]]></itunes:subtitle>
	<content:encoded><![CDATA[Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human healthspan. In this wide-ranging conversation, Chris and Andrew explore how PROSPR plans to accelerate the development of therapies that target aging itself by building the regulatory [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/94590/building-the-infrastructure-for-longevity-medicine-arpa-hs-prospr-program-dr-andrew-brack-program-manager.mp3" length="29150412" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human healthspan. In this wide-ranging conversation, Chris and Andrew explore how PROSPR plans to accelerate the development of therapies that target aging itself by building the regulatory [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Building the Infrastructure for Longevity Medicine: ARPA-H&#8217;s PROSPR Program (Dr. Andrew Brack, Program Manager)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>40:29</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Decoding Stem Cell Rejuvenation Factors (Markus Gstöttner, CEO of Clock.bio)</title>
	<link>https://podcasthealth.com/podcast/decoding-stem-cell-rejuvenation-factors-markus-gstottner-ceo-of-clock-bio/</link>
	<pubDate>Wed, 20 Nov 2024 13:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/decoding-stem-cell-rejuvenation-factors-markus-gstottner-ceo-of-clock-bio/</guid>
	<description><![CDATA[Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life by reversing the harmful effects of time in our cells. In this episode, Gstöttner shares how his company is working to extend healthspan by understanding and harnessing the natural rejuvenation capabilities of stem cells. The conversation explores [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life by reversing the harmful effects of time in our cells. In this episode, Gstöttner shares how his company is working to extend healthspan by underst]]></itunes:subtitle>
	<content:encoded><![CDATA[Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life by reversing the harmful effects of time in our cells. In this episode, Gstöttner shares how his company is working to extend healthspan by understanding and harnessing the natural rejuvenation capabilities of stem cells. The conversation explores [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/94592/decoding-stem-cell-rejuvenation-factors-markus-gstottner-ceo-of-clock-bio.mp3" length="64256737" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life by reversing the harmful effects of time in our cells. In this episode, Gstöttner shares how his company is working to extend healthspan by understanding and harnessing the natural rejuvenation capabilities of stem cells. The conversation explores [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Decoding Stem Cell Rejuvenation Factors (Markus Gstöttner, CEO of Clock.bio)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>26:46</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Eliminating Pathogenic Cells to Treat Disease (Adam Freund &#038; Remi Laberge, Arda Therapeutics)</title>
	<link>https://podcasthealth.com/podcast/eliminating-pathogenic-cells-to-treat-disease-adam-freund-remi-laberge-arda-therapeutics/</link>
	<pubDate>Wed, 30 Oct 2024 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/eliminating-pathogenic-cells-to-treat-disease-adam-freund-remi-laberge-arda-therapeutics/</guid>
	<description><![CDATA[Adam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel therapies that selectively eliminate harmful cell populations driving chronic diseases. In this episode, they discuss their innovative approach to treating conditions like idiopathic pulmonary fibrosis by identifying and removing specific cell types that cause tissue damage, rather [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Adam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel therapies that selectively eliminate harmful cell populations driving chronic diseases. In this episode, they discuss their innovativ]]></itunes:subtitle>
	<content:encoded><![CDATA[Adam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel therapies that selectively eliminate harmful cell populations driving chronic diseases. In this episode, they discuss their innovative approach to treating conditions like idiopathic pulmonary fibrosis by identifying and removing specific cell types that cause tissue damage, rather [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/94593/eliminating-pathogenic-cells-to-treat-disease-adam-freund-remi-laberge-arda-therapeutics.mp3" length="33009172" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Adam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel therapies that selectively eliminate harmful cell populations driving chronic diseases. In this episode, they discuss their innovative approach to treating conditions like idiopathic pulmonary fibrosis by identifying and removing specific cell types that cause tissue damage, rather [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Eliminating Pathogenic Cells to Treat Disease (Adam Freund &#038; Remi Laberge, Arda Therapeutics)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>45:51</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Precision Epigenetic Medicines to Extend Healthspan (Alex Aravanis,  Moonwalk Biosciences)</title>
	<link>https://podcasthealth.com/podcast/precision-epigenetic-medicines-to-extend-healthspan-alex-aravanis-moonwalk-biosciences/</link>
	<pubDate>Wed, 09 Oct 2024 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/precision-epigenetic-medicines-to-extend-healthspan-alex-aravanis-moonwalk-biosciences/</guid>
	<description><![CDATA[Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk&#8217;s innovative approach to developing a new class of medicines aimed at treating complex diseases and potentially extending human healthspan. The Finer Details: The concept of epigenetics as the &#8220;source code&#8221; [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk&#8217;s innovative approach to developing a new class of medicines aimed ]]></itunes:subtitle>
	<content:encoded><![CDATA[Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk&#8217;s innovative approach to developing a new class of medicines aimed at treating complex diseases and potentially extending human healthspan. The Finer Details: The concept of epigenetics as the &#8220;source code&#8221; [&#8230;]]]></content:encoded>
	<enclosure url="https://podcasthealth.com/podcast-download/94595/precision-epigenetic-medicines-to-extend-healthspan-alex-aravanis-moonwalk-biosciences.mp3" length="30293360" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk&#8217;s innovative approach to developing a new class of medicines aimed at treating complex diseases and potentially extending human healthspan. The Finer Details: The concept of epigenetics as the &#8220;source code&#8221; [&#8230;]]]></itunes:summary>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Precision Epigenetic Medicines to Extend Healthspan (Alex Aravanis,  Moonwalk Biosciences)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>42:04</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Hevolution: Extending Global Healthspan (Dr. Mehmood Khan, CEO)</title>
	<link>https://podcasthealth.com/podcast/hevolution-extending-global-healthspan-dr-mehmood-khan-ceo/</link>
	<pubDate>Wed, 17 Jul 2024 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/hevolution-extending-global-healthspan-dr-mehmood-khan-ceo/</guid>
	<description><![CDATA[In this episode, Chris Patil speaks with Dr. Mehmood Khan, CEO of Hevolution Foundation, about the organization&#8217;s mission to extend healthy human lifespan and better understand the aging process. Dr. Khan discusses Hevolution&#8217;s unique approach to funding global scientific discovery and investing in private companies dedicated to advancing aging science. He shares insights into the [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[In this episode, Chris Patil speaks with Dr. Mehmood Khan, CEO of Hevolution Foundation, about the organization&#8217;s mission to extend healthy human lifespan and better understand the aging process. Dr. Khan discusses Hevolution&#8217;s unique approac]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94597/hevolution-extending-global-healthspan-dr-mehmood-khan-ceo.mp3" length="31121735" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Hevolution: Extending Global Healthspan (Dr. Mehmood Khan, CEO)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>43:14</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Harnessing the Secretome to Combat Age-Related Immune Dysfunction (Dr. Hans Keirstead, Immunis)</title>
	<link>https://podcasthealth.com/podcast/harnessing-the-secretome-to-combat-age-related-immune-dysfunction-dr-hans-keirstead-immunis/</link>
	<pubDate>Wed, 08 May 2024 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/harnessing-the-secretome-to-combat-age-related-immune-dysfunction-dr-hans-keirstead-immunis/</guid>
	<description><![CDATA[Hans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits. In this episode, Chris and Hans discuss Immunis&#8217; approach to targeting the aging immune system as a key driver of age-related disease. They explore the potential of immune secretome factors [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Hans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits. In this episode, Chris and Hans discuss Immunis&#8217; approach to targeting]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94599/harnessing-the-secretome-to-combat-age-related-immune-dysfunction-dr-hans-keirstead-immunis.mp3" length="34298920" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Harnessing the Secretome to Combat Age-Related Immune Dysfunction (Dr. Hans Keirstead, Immunis)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>47:38</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Delaying menopause, extending healthspan: The promise of AMH-based therapeutics (Daisy Robinton, Oviva Therapeutics)</title>
	<link>https://podcasthealth.com/podcast/delaying-menopause-extending-healthspan-the-promise-of-amh-based-therapeutics-daisy-robinton-oviva-therapeutics/</link>
	<pubDate>Wed, 03 Apr 2024 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/delaying-menopause-extending-healthspan-the-promise-of-amh-based-therapeutics-daisy-robinton-oviva-therapeutics/</guid>
	<description><![CDATA[Dr. Daisy Robinton, co-founder and CEO of Oviva Therapeutics, discusses the company&#8217;s innovative approach to improving women&#8217;s healthspan by targeting the biology of ovarian aging. Motivated by her personal experiences and the realization that female physiology is underserved by research and medicine, Daisy outlines how menopause is a key inflection point in the acceleration of [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Daisy Robinton, co-founder and CEO of Oviva Therapeutics, discusses the company&#8217;s innovative approach to improving women&#8217;s healthspan by targeting the biology of ovarian aging. Motivated by her personal experiences and the realization tha]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94601/delaying-menopause-extending-healthspan-the-promise-of-amh-based-therapeutics-daisy-robinton-oviva-therapeutics.mp3" length="26340229" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Delaying menopause, extending healthspan: The promise of AMH-based therapeutics (Daisy Robinton, Oviva Therapeutics)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>36:35</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Gene Therapies to Treat and Reverse Aging (Noah Davidsohn, Rejuvenate Bio)</title>
	<link>https://podcasthealth.com/podcast/gene-therapies-to-treat-and-reverse-aging-noah-davidsohn-rejuvenate-bio/</link>
	<pubDate>Wed, 20 Mar 2024 21:15:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/gene-therapies-to-treat-and-reverse-aging-noah-davidsohn-rejuvenate-bio/</guid>
	<description><![CDATA[Dr. Noah Davidsohn, co-founder and CSO of Rejuvenate Bio, discusses the company&#8217;s innovative work using gene therapies to treat age-related diseases in dogs and humans. In his conversation with host Chris Patil, he explains his recent groundbreaking study showing that partial cellular reprogramming with Yamanaka factors extended lifespan and healthspan in very old mice. Noah [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Noah Davidsohn, co-founder and CSO of Rejuvenate Bio, discusses the company&#8217;s innovative work using gene therapies to treat age-related diseases in dogs and humans. In his conversation with host Chris Patil, he explains his recent groundbreakin]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94603/gene-therapies-to-treat-and-reverse-aging-noah-davidsohn-rejuvenate-bio.mp3" length="25333596" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Gene Therapies to Treat and Reverse Aging (Noah Davidsohn, Rejuvenate Bio)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>35:14</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>30 Years of Aging Biology: A Pioneer&#8217;s Perspective (Cynthia Kenyon, VP-Aging Research at Calico Labs)</title>
	<link>https://podcasthealth.com/podcast/30-years-of-aging-biology-a-pioneers-perspective-cynthia-kenyon-vp-aging-research-at-calico-labs/</link>
	<pubDate>Wed, 06 Dec 2023 13:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/30-years-of-aging-biology-a-pioneers-perspective-cynthia-kenyon-vp-aging-research-at-calico-labs/</guid>
	<description><![CDATA[30 Years of Aging Biology: A Pioneer’s Perspective (Cynthia Kenyon &#8211; VP Aging Biology, Calico Labs) Dr. Cynthia Kenyon reflects on the evolution of the longevity field over the 30 years since the publication of her groundbreaking paper, “A C. elegans mutant that lives twice as long as wild type,” a genetic analysis of one [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[30 Years of Aging Biology: A Pioneer’s Perspective (Cynthia Kenyon &#8211; VP Aging Biology, Calico Labs) Dr. Cynthia Kenyon reflects on the evolution of the longevity field over the 30 years since the publication of her groundbreaking paper, “A C. elega]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94605/30-years-of-aging-biology-a-pioneers-perspective-cynthia-kenyon-vp-aging-research-at-calico-labs.mp3" length="31750881" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>30 Years of Aging Biology: A Pioneer&#8217;s Perspective (Cynthia Kenyon, VP-Aging Research at Calico Labs)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>44:06</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>XPRIZE Healthspan: Catalyzing Therapies for Aging (Jamie Justice, PhD)</title>
	<link>https://podcasthealth.com/podcast/xprize-healthspan-catalyzing-therapies-for-aging-jamie-justice-phd/</link>
	<pubDate>Wed, 29 Nov 2023 21:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/xprize-healthspan-catalyzing-therapies-for-aging-jamie-justice-phd/</guid>
	<description><![CDATA[Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In conversation with host Chris Patil, Dr. Justice outlines the motivation, structure, and timeline of the prize, as well as how teams can get involved. She also explains unique aspects of this [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In conversation with host Chris Patil, Dr. Justice outlines the motivation, structure,]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94607/xprize-healthspan-catalyzing-therapies-for-aging-jamie-justice-phd.mp3" length="39730544" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>XPRIZE Healthspan: Catalyzing Therapies for Aging (Jamie Justice, PhD)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>55:16</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>&#8220;How We Age: The Science of Longevity&#8221; (Professor Coleen Murphy, Princeton)</title>
	<link>https://podcasthealth.com/podcast/how-we-age-the-science-of-longevity-professor-coleen-murphy-princeton/</link>
	<pubDate>Wed, 01 Nov 2023 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/how-we-age-the-science-of-longevity-professor-coleen-murphy-princeton/</guid>
	<description><![CDATA[Dr. Coleen Murphy is a prominent aging researcher and author of the upcoming book “How We Age: The Science of Longevity” from Princeton University Press. In this wide-ranging discussion, Coleen provides insights into her motivation for writing this book, key topics covered, and her unique perspective on the field. Key ideas: Addressing ethical concerns about [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Coleen Murphy is a prominent aging researcher and author of the upcoming book “How We Age: The Science of Longevity” from Princeton University Press. In this wide-ranging discussion, Coleen provides insights into her motivation for writing this book,]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94609/how-we-age-the-science-of-longevity-professor-coleen-murphy-princeton.mp3" length="26319257" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>&#8220;How We Age: The Science of Longevity&#8221; (Professor Coleen Murphy, Princeton)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>36:33</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>From Startup to Acquisition (Nick Hertz, Mitokinin)</title>
	<link>https://podcasthealth.com/podcast/from-startup-to-acquisition-nick-hertz-mitokinin/</link>
	<pubDate>Wed, 11 Oct 2023 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/from-startup-to-acquisition-nick-hertz-mitokinin/</guid>
	<description><![CDATA[Dr. Nicholas Hertz is the co-founder and former CSO of Mitokinin, a biotech company developing therapies targeting damaged mitochondria in neurodegenerative disease. Mitokinin was recently acquired by pharmaceutical giant AbbVie. In this episode, Nick recounts the journey from academic research on PINK1 biology to founding a startup and advancing a clinical candidate. He provides insights [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Nicholas Hertz is the co-founder and former CSO of Mitokinin, a biotech company developing therapies targeting damaged mitochondria in neurodegenerative disease. Mitokinin was recently acquired by pharmaceutical giant AbbVie. In this episode, Nick re]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94610/from-startup-to-acquisition-nick-hertz-mitokinin.mp3" length="30188503" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>From Startup to Acquisition (Nick Hertz, Mitokinin)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>41:59</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Catalyzing moonshots in longevity biotech (Alex Colville, Age1)</title>
	<link>https://podcasthealth.com/podcast/catalyzing-moonshots-in-longevity-biotech-alex-colville-age1/</link>
	<pubDate>Wed, 27 Sep 2023 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/catalyzing-moonshots-in-longevity-biotech-alex-colville-age1/</guid>
	<description><![CDATA[Dr. Alex Colville is the co-founder and General Partner of Age1 Ventures, a recently launched VC firm focused on funding contrarian, founder-led biotech companies aiming to extend healthy human lifespan. In this episode, Alex outlines Age1&#8217;s thesis of identifying and empowering talented founders with ambitious visions for the longevity field. He shares his own journey [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Alex Colville is the co-founder and General Partner of Age1 Ventures, a recently launched VC firm focused on funding contrarian, founder-led biotech companies aiming to extend healthy human lifespan. In this episode, Alex outlines Age1&#8217;s thesis]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94611/catalyzing-moonshots-in-longevity-biotech-alex-colville-age1.mp3" length="29160898" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Catalyzing moonshots in longevity biotech (Alex Colville, Age1)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>40:34</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Reversing Skin Aging at the Cellular Level (Carolina Reis Oliveira and Alessandra Zonari, OneSkin)</title>
	<link>https://podcasthealth.com/podcast/reversing-skin-aging-at-the-cellular-level-carolina-reis-oliveira-and-alessandra-zonari-oneskin/</link>
	<pubDate>Wed, 23 Aug 2023 12:30:00 +0000</pubDate>
	<dc:creator><![CDATA[PodcastHealth]]></dc:creator>
	<guid isPermaLink="false">https://podcasthealth.com/podcast/reversing-skin-aging-at-the-cellular-level-carolina-reis-oliveira-and-alessandra-zonari-oneskin/</guid>
	<description><![CDATA[Dr. Carolina Reis Oliveira and Dr. Alessandra Zonari are the co-founders of OneSkin, a company developing science-backed skincare products to reverse skin aging at the cellular level. In this episode, Carolina and Alessandra tell host Dr. Chris Patil how OneSkin is leveraging recent advances in longevity science to create novel peptides that target senescent cells [&#8230;]]]></description>
	<itunes:subtitle><![CDATA[Dr. Carolina Reis Oliveira and Dr. Alessandra Zonari are the co-founders of OneSkin, a company developing science-backed skincare products to reverse skin aging at the cellular level. In this episode, Carolina and Alessandra tell host Dr. Chris Patil how]]></itunes:subtitle>
	<enclosure url="https://podcasthealth.com/podcast-download/94612/reversing-skin-aging-at-the-cellular-level-carolina-reis-oliveira-and-alessandra-zonari-oneskin.mp3" length="25815941" type="audio/mpeg"></enclosure>
	<itunes:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></itunes:image>
	<ssp:image>
		<ssp:url>https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg</ssp:url>
		<ssp:title>Reversing Skin Aging at the Cellular Level (Carolina Reis Oliveira and Alessandra Zonari, OneSkin)</ssp:title>
	</ssp:image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>35:51</itunes:duration>
	<itunes:author><![CDATA[PodcastHealth]]></itunes:author>	<googleplay:image href="https://podcasthealth.com/wp-content/uploads/2025/07/2lGdvZBVXcVP2liVnv0l_vSc.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
